FS
MBOT icon

Financially Speaking’s Microbot Medical MBOT Stock Holding History

Financially Speaking’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3 Hold
1
– – ﹤0.01% 103
2026
Q1 		$3 Hold
1
– – ﹤0.01% 114
2025
Q4 		$2 Hold
1
– – ﹤0.01% 165
2025
Q3 		$3 Hold
1
– – ﹤0.01% 167
2025
Q2 		$3 Hold
1
– – ﹤0.01% 162
2025
Q1 		$2 Hold
1
– – ﹤0.01% 78
2024
Q4 		$1 Buy
+1
New +$1 ﹤0.01% 178

Other funds holding MBOT

AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
LCM
Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
BL
BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
API
Asset Planning Inc Cypress, California $154M AUM 25.18% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Financially Speaking's MBOT Position: Q2 2026 in Review

Financially Speaking held its Microbot Medical (MBOT) position steady in Q2 2026 at 1 share worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #103.

Financially Speaking first reported a position in MBOT in Q4 2024 and has held it in 7 quarters since. 15 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Financially Speaking held 1 share of Microbot Medical worth $3 as of Q2 2026.
  • Financially Speaking left its Microbot Medical share count unchanged in Q2 2026.
  • Microbot Medical made up ﹤0.01% of Financially Speaking's portfolio in Q2 2026, its #103 holding.
  • Financially Speaking first reported a position in Microbot Medical in Q4 2024 and has held it in 7 quarters since.
  • 15 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Financially Speaking's 13F filing for Q2 2026, filed 27 Jul 2026.